SHA/688837 (SHA/688837)

Shanghai Stock Exchange: SHA/688837 · CNY

CN¥37.6

+1.97 (+5.5%)· Recorded snapshot

Market cap	16.4B
Revenue (ttm)	1.1B
Net income (ttm)	408.5M
EPS (ttm)	CN¥1.11
Shares out	435.5M
P/E (trailing)	34.0x
Volume	7,640,901

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.1B
Net income (ttm): 408.5M
EPS (ttm): CN¥1.11
P/E (trailing): 34.0x
Market cap: 16.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E34

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC42.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHA/688837 indicators

Market & fundamental data

Available fields

152

Groups with data

Currency

CNY

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Employees	362
Employees change	43
Employees growth	13.48%
Enterprise value	CNY 16.7B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
Financial report date	2025-12-31
First seen	2026-09-20
Fiscal year end	December
Founded	2017
Industry	Biotechnology
Is primary listing	Yes
Last refreshed	2026-10-28
Market cap	CNY 16.4B
Price	CNY 37.57
Price currency	CNY
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	sha/688837
Website	https://www.evopointbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	2.94%
EV/Earnings	38.71x
EV/EBIT	34.52x
EV/EBITDA	31.73x
EV/FCF	74.69x
EV/Sales	14.23x
FCF / EV yield	1.34%
FCF yield	1.37%
Graham number	5.97613
Graham upside	-84.4%
Industry forward P/E	37.25x
P/(FCF - SBC) ratio	218.38x
P/(OCF - SBC) ratio	119.64x
P/B ratio	28.95x
P/E ratio	34x
P/FCF ratio	73.23x
P/OCF ratio	57.35x
P/S ratio	13.95x
Price / tangible book value	29.4x
Price/EBITDA ratio	31.61x
Sector forward P/E	20.26x
Sector P/E	37.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	41.23%
EBITDA margin	44.14%
Effective tax rate	21.19%
FCF margin	19.06%
Gross margin	100%
Operating margin	41.23%
Pretax margin	46.66%
Profit margin	36.77%
Profit per employee	CNY 1.1M
Revenue per employee	CNY 3.1M
ROCE	32.01%
ROIC	42.65%
SBC / revenue	12.67%
Tax / revenue	9.89%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -58.6M
Depreciation and amortization	CNY 32.3M
EBIT	CNY 458.1M
EBITDA	CNY 490.4M
EPS	CNY 1.11
FCF per share	CNY 0.49
Financing cash flow	CNY 410.2M
Free cash flow	CNY 211.7M
Free cash flow minus SBC	CNY 71M
Gross profit	CNY 1.1B
Income taxes	CNY 109.9M
Investing cash flow	CNY -199M
Net borrowing	CNY 457M
Net cash flow	CNY 467.2M
Net income	CNY 408.5M
Operating cash flow minus SBC	CNY 129.6M
Operating income	CNY 458.1M
Revenue	CNY 1.1B
Stock-based compensation	CNY 140.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CNY 1.44
Debt / EBITDA	2.6
Debt / equity	2.42
Debt / FCF	6.11
Interest coverage	19.2
Long-term assets	CNY 1.1B
Long-term liabilities	CNY 1.1B
Net cash (debt)	CNY -310.8M
Net cash / market cap	-2%
Net debt / EBITDA	0.63
Net debt / equity	0.58
Net debt / FCF	1.47
Piotroski F-Score	2
Property, plant and equipment	CNY 429.4M
Shareholders' equity	CNY 535.6M
Tangible book value	CNY 527.3M
Tangible book value per share	CNY 1.41
Total assets	CNY 2B
Total cash	CNY 983.4M
Total debt	CNY 1.3B
Total liabilities	CNY 1.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CNY 911.6M
Current liabilities	CNY 308.9M
Current ratio	2
Net working capital	CNY -36.5M
Quick ratio	1.8
Working capital	CNY 545.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-8.25%
Payout ratio	6.62%
Shareholder yield	-8.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	5.53%
1M price change	-20.59%
1M total return	-20.59%
1W price change	-6.68%
1W total return	-6.68%
20-day SMA	CNY 42.72
52-week high	CNY 78.98
52-week high date	2026-09-18
52-week low	CNY 35.58
52-week low date	2026-10-27
All-time high	CNY 78.98
All-time high date	2026-09-18
All-time low	CNY 35.58
All-time low date	2026-10-27
Average true range (ATR)	CNY 5.86
Average volume	10.3M
Beta (1Y)	0.69
Change from 52-week high	-52.43%
Change from 52-week low	5.59%
Change from all-time high	-52.43%
Change from all-time low	5.59%
Change from open	5.3%
Day's gap	0.22%
Dollar volume	CNY 287.1M
High price	CNY 39.12
Low price	CNY 35.61
Monthly RSI	0
Open price	CNY 35.68
Position in 52-week range	55.84%
Previous close	CNY 35.60
Price vs 20-day SMA	-12.06%
Relative volume	0.68
RSI	47.38
Sharpe ratio	0.17
Sortino ratio	0.39
Volume	7.6M
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	111.8M
Shares change (QoQ)	-0.95%
Shares change (YoY)	8.25%
Shares held by insiders	5.39%
Shares held by institutions	12.47%
Shares outstanding	435.5M

Deeper analysis on SHA/688837

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHA/688837 report

Is a complete SHA/688837 research report available?

No complete published report is available for sha/688837 (SHA/688837) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHA/688837 (SHA/688837)

Price

Financial snapshot

Fair-value bridge

Latest news · SHA/688837

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHA/688837 indicators

Profile and market data

Valuation

Profitability

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHA/688837

Frequently asked questions